International Cancer Center Offers Patients Chance to Shrink Large Metastatic Liver Tumors within Several Months
Liver Cancer Centers of America offers Patients with Metastatic Liver Disease Chance to Reduce Large Tumor Loads into Significantly Smaller Tumor Loads, Setting Stage for Near Term Ablation.
HOUSTON, Sept. 6, 2018 /PRNewswire-PRWeb/ -- Gregory DiRienzo, CEO Integrative Cancer Centers of America (http://www.integrativecancercentersofamerica.com) and Liver Cancer Centers of America announces the opening of Liver Cancer Centers of America in the River Oaks district of Houston, Texas.
LCCA Houston, through its cancer centers located outside the United States, offers metastatic liver patients, CoNexus Care, a cutting-edge neoadjuvancy treatment program designed to greatly reduce large tumor loads into small tumor loads, setting stage for suitable ablation within weeks after commencing treatment. DiRienzo says that advanced pancreatic cancer patients can potentially benefit from CoNexus Care as well.
CoNexus Care has been clinically shown for over thirty years to reduce, limit and even debulk many primary and metastatic tumors, even those considered untreatable by many respected cancer centers. CoNexus Care has also been shown to strengthen and enhance the patient's overall immune system, which is often greatly compromised, as a result of protracted chemotherapy treatment or other conventional cancer treatments.
Both LCCA Houston and affiliated cancer centers abroad, integrate highly trained, board-certified physicians, who employ safe and effective treatments designed to eliminate cancerous tumor/cells without compromising the patient's quality of life. LCCA physicians have practiced in many global venues including Germany, United States, South Korea, Mexico, Canada, and Cuba.
Email: info(at)integrativecancercentersofamerica.com
Integrative Cancer Centers of America
Baja California, MX
001.800.205.8101
SOURCE: ICCA
SOURCE Integrative Cancer Centers of America
Share this article